Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Incontinence, Stress | 5 | 2020 | 23 | 1.070 |
Why?
|
| Urinary Bladder, Overactive | 3 | 2023 | 6 | 1.040 |
Why?
|
| Suburethral Slings | 4 | 2020 | 21 | 1.020 |
Why?
|
| Urinary Incontinence | 3 | 2014 | 40 | 0.620 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 415 | 0.590 |
Why?
|
| Surgical Mesh | 4 | 2016 | 58 | 0.580 |
Why?
|
| Prostatectomy | 2 | 2014 | 64 | 0.540 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2016 | 2 | 0.530 |
Why?
|
| Urinary Retention | 4 | 2022 | 31 | 0.500 |
Why?
|
| Urologic Surgical Procedures | 4 | 2016 | 30 | 0.470 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2023 | 16 | 0.410 |
Why?
|
| Urinary Tract Infections | 2 | 2023 | 80 | 0.390 |
Why?
|
| Urodynamics | 2 | 2010 | 13 | 0.370 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2010 | 6 | 0.360 |
Why?
|
| Spinal Dysraphism | 1 | 2010 | 16 | 0.350 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2016 | 41 | 0.290 |
Why?
|
| Kidney Neoplasms | 2 | 2006 | 125 | 0.290 |
Why?
|
| Uterine Prolapse | 1 | 2006 | 13 | 0.270 |
Why?
|
| Pelvic Floor | 1 | 2006 | 10 | 0.270 |
Why?
|
| Heart Arrest, Induced | 1 | 2006 | 12 | 0.270 |
Why?
|
| Vena Cava, Inferior | 1 | 2006 | 28 | 0.260 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2006 | 83 | 0.260 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2006 | 5 | 0.260 |
Why?
|
| Treatment Outcome | 9 | 2013 | 5281 | 0.250 |
Why?
|
| Bladder Exstrophy | 1 | 2004 | 1 | 0.230 |
Why?
|
| Thrombectomy | 1 | 2006 | 208 | 0.230 |
Why?
|
| Thrombosis | 1 | 2006 | 182 | 0.220 |
Why?
|
| Cystitis, Interstitial | 3 | 2009 | 5 | 0.220 |
Why?
|
| Electric Stimulation Therapy | 3 | 2007 | 27 | 0.210 |
Why?
|
| Humans | 24 | 2023 | 59389 | 0.200 |
Why?
|
| Female | 18 | 2023 | 30724 | 0.190 |
Why?
|
| Denervation | 1 | 2019 | 17 | 0.160 |
Why?
|
| Aged | 10 | 2022 | 13406 | 0.150 |
Why?
|
| Cauda Equina | 2 | 2007 | 7 | 0.140 |
Why?
|
| Male | 13 | 2023 | 27747 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 32 | 0.130 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2016 | 24 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2014 | 3067 | 0.120 |
Why?
|
| Surveys and Questionnaires | 3 | 2014 | 2516 | 0.120 |
Why?
|
| Middle Aged | 10 | 2014 | 16314 | 0.120 |
Why?
|
| Urinary Bladder | 2 | 2022 | 38 | 0.110 |
Why?
|
| Incontinence Pads | 1 | 2014 | 2 | 0.110 |
Why?
|
| Adult | 9 | 2022 | 15683 | 0.110 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2014 | 23 | 0.110 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2013 | 47 | 0.110 |
Why?
|
| Electrodes, Implanted | 3 | 2007 | 37 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2023 | 6071 | 0.110 |
Why?
|
| Infant | 2 | 2010 | 1492 | 0.100 |
Why?
|
| Aged, 80 and over | 5 | 2014 | 5119 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 2338 | 0.100 |
Why?
|
| Epidural Space | 2 | 2007 | 6 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2023 | 331 | 0.090 |
Why?
|
| Time Factors | 2 | 2014 | 3615 | 0.080 |
Why?
|
| Quality of Life | 3 | 2014 | 1137 | 0.070 |
Why?
|
| Lumbosacral Plexus | 1 | 2007 | 5 | 0.070 |
Why?
|
| Sexuality | 1 | 2007 | 25 | 0.070 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2007 | 21 | 0.070 |
Why?
|
| Pelvic Pain | 1 | 2007 | 18 | 0.070 |
Why?
|
| Salvage Therapy | 1 | 2007 | 71 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2008 | 270 | 0.070 |
Why?
|
| Polypropylenes | 1 | 2006 | 6 | 0.070 |
Why?
|
| Age Factors | 1 | 2010 | 1504 | 0.070 |
Why?
|
| Sternum | 1 | 2006 | 27 | 0.070 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2006 | 53 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 705 | 0.060 |
Why?
|
| United States Food and Drug Administration | 2 | 2016 | 85 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2010 | 1793 | 0.060 |
Why?
|
| Public Health | 2 | 2016 | 176 | 0.060 |
Why?
|
| Premedication | 1 | 2003 | 16 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2004 | 39 | 0.060 |
Why?
|
| Lactones | 1 | 2003 | 24 | 0.050 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2003 | 6 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2003 | 52 | 0.050 |
Why?
|
| Prostate | 1 | 2003 | 65 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 132 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 118 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2003 | 71 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2008 | 2375 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 202 | 0.050 |
Why?
|
| Child | 1 | 2010 | 4189 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2002 | 145 | 0.040 |
Why?
|
| Young Adult | 1 | 2010 | 4272 | 0.040 |
Why?
|
| Pain | 1 | 2003 | 396 | 0.040 |
Why?
|
| Risk Factors | 1 | 2010 | 4986 | 0.040 |
Why?
|
| Adolescent | 1 | 2010 | 5838 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2004 | 1284 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 454 | 0.040 |
Why?
|
| Dilatation | 2 | 2009 | 30 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 735 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2004 | 1204 | 0.030 |
Why?
|
| Fascia | 1 | 2016 | 5 | 0.030 |
Why?
|
| Gynecology | 1 | 2016 | 50 | 0.030 |
Why?
|
| Urology | 1 | 2016 | 36 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 272 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2009 | 914 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 308 | 0.030 |
Why?
|
| United States | 2 | 2016 | 7426 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 692 | 0.020 |
Why?
|
| Hydroxyzine | 1 | 2009 | 2 | 0.020 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2009 | 2 | 0.020 |
Why?
|
| Nitrofurantoin | 1 | 2009 | 10 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1559 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1479 | 0.020 |
Why?
|
| Endoscopy | 1 | 2009 | 98 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 354 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2009 | 161 | 0.020 |
Why?
|
| Necrosis | 1 | 2007 | 140 | 0.020 |
Why?
|
| Water | 1 | 2007 | 300 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 717 | 0.010 |
Why?
|
| Sulfones | 1 | 2003 | 36 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2003 | 16 | 0.010 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2003 | 4 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 2003 | 44 | 0.010 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 1 | 2002 | 2 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 188 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2003 | 92 | 0.010 |
Why?
|
| Exons | 1 | 2003 | 191 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2002 | 66 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2002 | 185 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 715 | 0.010 |
Why?
|
| Biopsy | 1 | 2002 | 410 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1091 | 0.010 |
Why?
|